Defining B cell immunodominance to viruses

Nature Immunology

Volumn 18, Issue 4, 2017, Pages 456-463

  Angeletti, Davide ^a   Gibbs, James S ^a   Angel, Matthew ^a   Kosik, Ivan ^a   Hickman, Heather D ^a   Frank, Gregory M ^a   Das, Suman R ^a,b   Wheatley, Adam K ^a   Prabhakaran, Madhu ^a   Leggat, David J ^a   McDermott, Adrian B ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; EPITOPE; VIRUS ANTIBODY; VIRUS ANTIGEN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNODOMINANCE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; ANIMAL; BLOOD; CD4+ T LYMPHOCYTE; CHEMISTRY; GENETIC BACKGROUND; GENETICS; HOST PATHOGEN INTERACTION; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA A VIRUS; LYMPH NODE; METABOLISM; MOLECULAR MODEL; ORTHOMYXOVIRUS INFECTION; PROTEIN CONFORMATION; VIROLOGY; VIRUS; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; GENETIC BACKGROUND; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HOST-PATHOGEN INTERACTIONS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; LYMPH NODES; MICE; MODELS, MOLECULAR; ORTHOMYXOVIRIDAE INFECTIONS; PROTEIN CONFORMATION; VIRUS DISEASES; VIRUSES;

EID: 85012241721     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3680     Document Type: Article

References (45)

1. Yewdell, J.W. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25, 533-543 (2006).
2. Krammer, F. & Palese, P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 14, 167-182 (2015).
3. Burton, D.R., Poignard, P., Stanfield, R.L. & Wilson, I.A. Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337, 183-186 (2012).
4. Wheatley, A.K. & Kent, S.J. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. Expert Rev. Vaccines 14, 1227-1239 (2015).
5. Victora, G.D. & Wilson, P.C. Germinal center selection and the antibody response to influenza. Cell 163, 545-548 (2015).
6. Hutchinson, E.C. et al. Conserved and host-specific features of influenza virion architecture. Nat. Commun. 5, 4816 (2014).
7. Reading, S.A. & Dimmock, N.J. Neutralization of animal virus infectivity by antibody. Arch. Virol. 152, 1047-1059 (2007).
8. Altman, M.O., Bennink, J.R., Yewdell, J.W. & Herrin, B.R. Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity. eLife 4, e07467 (2015).
9. Caton, A.J., Brownlee, G.G., Yewdell, J.W. & Gerhard, W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417-427 (1982).
10. Gerhard, W., Yewdell, J., Frankel, M.E. & Webster, R. Antigenic structure of influenza virus hemagglutinin defined by hybridoma antibodies. Nature 290, 713-717 (1981).
11. Yewdell, J.W., Webster, R.G. & Gerhard, W.U. Antigenic variation in three distinct determinants of an influenza type A hemagglutinin molecule. Nature 279, 246-248 (1979).
12. Kavaler, J., Caton, A.J., Staudt, L.M., Schwartz, D. & Gerhard, W. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. J. Immunol. 145, 2312-2321 (1990).
13. McKean, D. et al. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 81, 3180-3184 (1984).
14. Staudt, L.M. & Gerhard, W. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J. Exp. Med. 157, 687-704 (1983).
15. Das, S.R. et al. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host Microbe 13, 314-323 (2013).
16. Lubeck, M. & Gerhard, W. Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. Virology 118, 1-7 (1982).
17. Marshall, D., Sealy, R., Sangster, M. & Coleclough, C. TH cells primed during influenza virus infection provide help for qualitatively distinct antibody responses to subsequent immunization. J. Immunol. 163, 4673-4682 (1999).
18. Rothaeusler, K. & Baumgarth, N. B cell fate decisions following influenza virus infection. Eur. J. Immunol. 40, 366-377 (2010).
19. Sealy, R., Surman, S., Hurwitz, J.L. & Coleclough, C. Antibody response to influenza infection of mice: different patterns for glycoprotein and nucleocapsid antigens. Immunology 108, 431-439 (2003).
20. Baumgarth, N. How specific is too specific? B cell responses to viral infections reveal the importance of breadth over depth. Immunol. Rev. 255, 82-94 (2013).
21. Whittle, J.R. et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages. J. Virol. 88, 4047-4057 (2014).
22. Frank, G.M. et al. A simple flow-cytometric method measuring B cell surface immunoglobulin avidity enables characterization of affinity maturation to influenza A virus. MBio 6, e01156 (2015).
23. Tsilibary, E.C. & Wissig, S.L. Light and electron microscope observations of the lymphatic drainage units of the peritoneal cavity of rodents. Am. J. Anat. 180, 195-207 (1987).
24. Lee, B.O. et al. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J. Immunol. 175, 5827-5838 (2005).
25. Mozdzanowska, K., Furchner, M., Zharikova, D., Feng, J. & Gerhard, W. Roles of CD4+ T cell-independent and T cell-dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T cell activities that enhance the therapeutic activity of antiviral antibodies. J. Virol. 79, 5943-5951 (2005).
26. Hai, R. et al. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J. Virol. 86, 5774-5781 (2012).
27. Bennink, J.R. & Doherty, P.C. The response to H-2-different virus-infected cells is mediated by long-lived T lymphocytes and is diminished by prior virus priming in a syngeneic environment. Cell. Immunol. 61, 220-224 (1981).
28. Jamieson, B.D. & Ahmed, R. T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J. Exp. Med. 169, 1993-2005 (1989).
29. Kim, J.H., Skountzou, I., Compans, R. & Jacob, J. Original antigenic sin responses to influenza viruses. J. Immunol. 183, 3294-3301 (2009).
30. Kavaler, J., Caton, A.J., Staudt, L.M. & Gerhard, W. A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. Eur. J. Immunol. 21, 2687-2695 (1991).
31. Churchill, G.A. et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 36, 1133-1137 (2004).
32. Linderman, S.L. et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc. Natl. Acad. Sci. USA 111, 15798-15803 (2014).
33. Jelley-Gibbs, D.M. et al. Unexpected prolonged presentation of influenza antigens promotes CD4 T cell memory generation. J. Exp. Med. 202, 697-706 (2005).
34. Waffarn, E.E. & Baumgarth, N. Protective B cell responses to flu-no fluke! J. Immunol. 186, 3823-3829 (2011).
35. MacLennan, I.C.M. Germinal centers. Annu. Rev. Immunol. 12, 117-139 (1994).
36. Hollowood, K. & Macartney, J. Cell kinetics of the germinal center reaction- a stathmokinetic study. Eur. J. Immunol. 22, 261-266 (1992).
37. Zammit, D.J., Turner, D.L., Klonowski, K.D., Lefrancois, L. & Cauley, L.S. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity 24, 439-449 (2006).
38. Webster, R.G., Fazekas de St.Groth, S. & Webster, R.G. Disquisition on original antigenic sin. I. Evidence in man. J. Exp. Med. 124, 331-345 (1966).
39. Kim, J.H., Davis, W.G., Sambhara, S. & Jacob, J. Strategies to alleviate original antigenic sin responses to influenza viruses. Proc. Natl. Acad. Sci. USA 109, 13751-13756 (2012).
40. Andrews, S.F. et al. High pre-existing serological antibody levels correlate with diversification of the influenza vaccine response. J. Virol. 89, 3308-3317 (2015).
41. Sasaki, S. et al. Influence of prior influenza vaccination on antibody and B cell responses. PLoS One 3, e2975 (2008).
42. Fleishman, S.J. et al. Computational design of proteins targeting the conserved stem region of influenza hemagglutinin. Science 332, 816-821 (2011).
43. Gamblin, S.J. et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838-1842 (2004).
44. Yewdell, J.W. & Gerhard, W. Antigenic characterization of viruses by monoclonal antibodies. Annu. Rev. Microbiol. 35, 185-206 (1981).
45. Pieri, L., Sassoli, C., Romagnoli, P. & Domenici, L. Use of periodate-lysine-paraformaldehyde for the fixation of multiple antigens in human skin biopsies. Eur. J. Histochem. 46, 365-375 (2002).